Literature DB >> 17127423

Multisite phosphorylation of the cAMP response element-binding protein (CREB) by a diversity of protein kinases.

Mona Johannessen1, Ugo Moens.   

Abstract

The prevailing view of stimulus-induced activation of the transcription factor cAMP response element-binding protein (CREB) presumes phosphorylation at serine-133. Although, phosphorylation of this residue seems to be necessary, it is not sufficient to trigger CREB-driven transcription, indicating that other phosphoserine-133-independent mechanisms are required for full activation of CREB. One of these additional regulatory mechanisms influencing the transcriptional state of CREB may involve multiple phosphorylation events on other phosphoacceptor sites in the protein. This review focuses on the phosphorylation modifications of CREB by distinct protein kinases and discusses the possible implications for the function of CREB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127423     DOI: 10.2741/2190

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  51 in total

1.  Targeting CREB for cancer therapy: friend or foe.

Authors:  Xiangshu Xiao; Bingbing X Li; Bryan Mitton; Alan Ikeda; Kathleen M Sakamoto
Journal:  Curr Cancer Drug Targets       Date:  2010-06       Impact factor: 3.428

Review 2.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

Review 3.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

4.  Structural Basis for Graded Inhibition of CREB:DNA Interactions by Multisite Phosphorylation.

Authors:  Sergey Shnitkind; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2018-12-13       Impact factor: 3.162

5.  Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.

Authors:  Xuehong Deng; Han Liu; Jiaoti Huang; Liang Cheng; Evan T Keller; Sarah J Parsons; Chang-Deng Hu
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

6.  Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.

Authors:  Xuehong Deng; Bennett D Elzey; Jean M Poulson; Wallace B Morrison; Song-Chu Ko; Noah M Hahn; Timothy L Ratliff; Chang-Deng Hu
Journal:  Am J Cancer Res       Date:  2011-08-18       Impact factor: 6.166

7.  AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.

Authors:  Nanao Horike; Hideyuki Sakoda; Akifumi Kushiyama; Hiraku Ono; Midori Fujishiro; Hideaki Kamata; Koichi Nishiyama; Yasunobu Uchijima; Yukiko Kurihara; Hiroki Kurihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 8.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

9.  Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase.

Authors:  Nisheeth Agarwal; Gyanu Lamichhane; Radhika Gupta; Scott Nolan; William R Bishai
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

10.  Expression of cAMP response element-binding protein in the duct system of the mouse submandibular gland.

Authors:  Sunisa Keattikunpairoj; Tomohiko Wakayama; Miyuki Yamamoto; Masa-aki Nakaya; Hiroki Nakata; Wiphawi Hipkaeo; Natthiya Sakulsak; Shoichi Iseki
Journal:  Histochem Cell Biol       Date:  2009-10-17       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.